These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32770184)

  • 21. N2 lung cancer is not all the same: an analysis of different prognostic groups.
    Bertoglio P; Ricciardi S; Alì G; Aprile V; Korasidis S; Palmiero G; Fontanini G; Mussi A; Lucchi M
    Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):720-726. PubMed ID: 29788107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†.
    Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Spaggiari L; Ratto GB; Filosso PL; Facciolo F
    Eur J Cardiothorac Surg; 2019 Mar; 55(3):405-412. PubMed ID: 30202953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
    Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
    Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
    Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
    J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
    Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
    Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non-small-cell Lung Cancer: A Propensity Score Matching Analysis.
    Wang L; Zhan C; Gu J; Xi J; Lin Z; Xue L; Ge D; Wang Q
    Clin Lung Cancer; 2019 May; 20(3):e346-e355. PubMed ID: 30665872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer.
    Lee GD; Kim DK; Moon DH; Joo S; Hwang SK; Choi SH; Kim HR; Kim YH; Park SI
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):580-8. PubMed ID: 25890940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgically Resected Non-Small-Cell Lung Cancer Patients.
    Wang Z; Yang Z; Li S; Zhang J; Xia L; Zhou J; Chen N; Guo C; Liu L
    Ann Surg Oncol; 2022 Dec; 29(13):8144-8153. PubMed ID: 35980551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of the N1 classification pattern: a meta-analysis of different subclassification methods.
    Wang Z; Yang H; Hao X; Zhou J; Chen N; Pu Q; Liu L
    Eur J Cardiothorac Surg; 2021 Apr; 59(3):545-553. PubMed ID: 33253363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommended changes for the 8th edition of the TNM classification for lung cancer-the findings of a single-institution evaluation.
    Wang J; Wu N; Lv C; Yan S; Yang Y
    Ann Transl Med; 2020 Feb; 8(4):123. PubMed ID: 32175416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of the current Japanese nodal classification on outcomes in resected non-small cell lung cancer.
    Ichinose J; Murakawa T; Hino H; Konoeda C; Inoue Y; Kitano K; Nagayama K; Nitadori JI; Anraku M; Nakajima J
    Chest; 2014 Sep; 146(3):644-649. PubMed ID: 24811857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Where is the boundary between N1 and N2 stations in lung cancer?
    Asamura H; Suzuki K; Kondo H; Tsuchiya R
    Ann Thorac Surg; 2000 Dec; 70(6):1839-45; discussion 1845-6. PubMed ID: 11156081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skip N2 Metastasis in Pulmonary Adenocarcinoma: Good Prognosis Similar to N1 Disease.
    Wang L; Ye G; Xue L; Zhan C; Gu J; Xi J; Lin Z; Jiang W; Ge D; Wang Q
    Clin Lung Cancer; 2020 Sep; 21(5):e423-e434. PubMed ID: 32245623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
    Liu K; Chen HL; You QS; Huang JF; Wang H
    Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.